The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Inhibition of Bacterial Biofilm Formation and Swarming Motility by a Small Synthetic Cationic Peptide
Open accessAbstract
Biofilms cause up to 80% of infections and are difficult to treat due to their substantial multidrug resistance compared to their planktonic counterparts. Based on the observation that human peptide LL-37 is able to block biofilm formation at concentrations below its MIC, we screened for small peptides with antibiofilm activity and identified novel synthetic cationic peptide 1037 of only 9 amino acids in length. Peptide 1037 had very weak antimicrobial activity, but at 1/30th the MIC the peptide was able to effectively prevent biofilm formation (>50% reduction in cell biomass) by the Gram-negative pathogens Pseudomonas aeruginosa and Burkholderia cenocepacia and Gram-positive Listeria monocytogenes . Using a flow cell system and a widefield fluorescence microscope, 1037 was shown to significantly reduce biofilm formation and lead to cell death in biofilms. Microarray and follow-up studies showed that, in P. aeruginosa , 1037 directly inhibited biofilms by reducing swimming and swarming motilities, stimulating twitching motility, and suppressing the expression of a variety of genes involved in biofilm formation (e.g., PA2204). Comparison of microarray data from cells treated with peptides LL-37 and 1037 enabled the identification of 11 common P. aeruginosa genes that have a role in biofilm formation and are proposed to represent functional targets of these peptides. Peptide 1037 shows promise as a potential therapeutic agent against chronic, recurrent biofilm infections caused by a variety of bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
Self-citationAntimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Self-citationAntimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Self-citationUnderstanding biofilm resistance to antibacterial agents
Davies, D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,781
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Self-citationSurvival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,812
Pseudomonas aeruginosa Displays Multiple Phenotypes during Development as a Biofilm
Sauer, K., Camper, A. K., Ehrlich, G. D., Costerton, J. W., & Davies, D. G. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.4.1140-1154.2002 · Cited by 1,691 · cited 3×
“As expected, flagellar genes were downregulated, as were genes ( nirS , norC , and nosZ ) known to play a role in anaerobic biofilm developmental process by encoding proteins involved in anaerobic respiration (53, 64).”
InfluentialQuorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519
Aminoglycoside antibiotics induce bacterial biofilm formation
Hoffman, L. R., D'Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., & Miller, S. I. (2005) · Nature · doi:10.1038/nature03912 · Cited by 1,321
Cited by
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
The value of antimicrobial peptides in the age of resistance
Magana, M., Pushpanathan, M., Santos, A. L., Leanse, L., Fernandez, M., Ioannidis, A., Giulianotti, M. A., Apidianakis, Y., Bradfute, S., Ferguson, A. L., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30327-3 · Cited by 1,150
Self-citationde la Fuente-Núñez, C., Reffuveille, F., Fernández, L., & Hancock, R. E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.013 · Cited by 801
Self-citationMechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities
Luo, Y., & Song, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111401 · Cited by 559
Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
de la Fuente-Núñez, C., Reffuveille, F., Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004152 · Cited by 521
Self-citationGan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Hall, B. G., Acar, H., Nandipati, A., & Barlow, M. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/mst187 · Cited by 507
Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
Pfalzgraff, A., Brandenburg, K., & Weindl, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00281 · Cited by 481
Type IV Pilin Proteins: Versatile Molecular Modules
Giltner, C. L., Nguyen, Y., & Burrows, L. L. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00035-12 · Cited by 472
Self-citationAntimicrobial peptides (AMPs): A promising class of antimicrobial compounds
Erdem Büyükkiraz, M., & Kesmen, Z. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15314 · Cited by 454
Peptide Design Principles for Antimicrobial Applications
Torres, M. D. T., Sothiselvam, S., Lu, T. K., & de la Fuente-Nunez, C. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.12.015 · Cited by 438
Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria
Batoni, G., Maisetta, G., & Esin, S. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.013 · Cited by 401
Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions
Raheem, N., & Straus, S. K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02866 · Cited by 369
Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities
Penesyan, A., Gillings, M., & Paulsen, I. (2015) · Molecules · doi:10.3390/molecules20045286 · Cited by 363
Reassessing the Host Defense Peptide Landscape
Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00043 · Cited by 359
Self-citationSrinivasan, R., Santhakumari, S., Poonguzhali, P., Geetha, M., Dyavaiah, M., & Xiangmin, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.676458 · Cited by 352
Antimicrobial Peptides: A Potent Alternative to Antibiotics
Rima, M., Rima, M., Fajloun, Z., Sabatier, J.-M., Bechinger, B., & Naas, T. (2021) · Antibiotics · doi:10.3390/antibiotics10091095 · Cited by 350
Taylor, P. K., Yeung, A. T. Y., & Hancock, R. E. W. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.09.003 · Cited by 340
Self-citationMethicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype
Craft, K. M., Nguyen, J. M., Berg, L. J., & Townsend, S. D. (2019) · MedChemComm · doi:10.1039/c9md00044e · Cited by 332
Marine Biofilms: A Successful Microbial Strategy With Economic Implications
de Carvalho, C. C. C. R. (2018) · Frontiers in Marine Science · doi:10.3389/fmars.2018.00126 · Cited by 331
Approaches to Dispersing Medical Biofilms
Fleming, D., & Rumbaugh, K. (2017) · Microorganisms · doi:10.3390/microorganisms5020015 · Cited by 329
de la Fuente-Núñez, C., Reffuveille, F., Mansour, S. C., Reckseidler-Zenteno, S. L., Hernández, D., Brackman, G., Coenye, T., & Hancock, R. E. W. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.01.002 · Cited by 323
Self-citationTripathi, N., & Goshisht, M. K. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00014 · Cited by 320
Action of Antimicrobial Peptides against Bacterial Biofilms
Yasir, M., Willcox, M. D. P., & Dutta, D. (2018) · Materials · doi:10.3390/ma11122468 · Cited by 319
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Self-citationHaney, E., Trimble, M., Cheng, J., Vallé, Q., & Hancock, R. (2018) · Biomolecules · doi:10.3390/biom8020029 · Cited by 308
Self-citationControl of Biofilm Formation: Antibiotics and Beyond
Algburi, A., Comito, N., Kashtanov, D., Dicks, L. M. T., & Chikindas, M. L. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.02508-16 · Cited by 299
Microtiter plate assays to assess antibiofilm activity against bacteria
Haney, E. F., Trimble, M. J., & Hancock, R. E. W. (2021) · Nature Protocols · doi:10.1038/s41596-021-00515-3 · Cited by 295
Self-citationA Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms
Reffuveille, F., de la Fuente-Núñez, C., Mansour, S., & Hancock, R. E. W. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03163-14 · Cited by 293
Self-citationPeptide design for antimicrobial and immunomodulatory applications
Haney, E. F., & Hancock, R. E. W. (2013) · Peptide Science · doi:10.1002/bip.22250 · Cited by 291
Self-citationAgents that Inhibit Bacterial Biofilm Formation
Rabin, N., Zheng, Y., Opoku-Temeng, C., Du, Y., Bonsu, E., & Sintim, H. O. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.7 · Cited by 273
Gastrointestinal biofilms in health and disease
Motta, J.-P., Wallace, J. L., Buret, A. G., Deraison, C., & Vergnolle, N. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00397-y · Cited by 270
Antibiofilm activity of host defence peptides: complexity provides opportunities
Hancock, R. E. W., Alford, M. A., & Haney, E. F. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00585-w · Cited by 270
Self-citationLactobacillus plantarum lipoteichoic acid inhibits biofilm formation of Streptococcus mutans
Ahn, K. B., Baik, J. E., Park, O.-J., Yun, C.-H., & Han, S. H. (2018) · PLOS ONE · doi:10.1371/journal.pone.0192694 · Cited by 113
Treatment of Oral Multispecies Biofilms by an Anti-Biofilm Peptide
Wang, Z., de la Fuente-Núñez, C., Shen, Y., Haapasalo, M., & Hancock, R. E. W. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132512 · Cited by 73
Self-citationAntimicrobial peptides for bone tissue engineering: Diversity, effects and applications
Hao, Z., Chen, R., Chai, C., Wang, Y., Chen, T., Li, H., Hu, Y., Feng, Q., & Li, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1030162 · Cited by 47
Azadi, S., Yazdanpanah, M. A., Afshari, A., Alahdad, N., Chegeni, S., Angaji, A., Rezayat, S. M., & Tavakol, S. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241303818 · Cited by 24
Metadata
- Authors
- de la Fuente-Núñez, C., Korolik, V., Bains, M., Nguyen, U., Breidenstein, E. B. M., Horsman, S., Lewenza, S., Burrows, L., & Hancock, R. E. W.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2012-05
- Volume
- 56
- Issue
- 5
- Pages
- 2696-2704
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2109328764
- Cited by
- 459
- References
- 59
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.